Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia-Reference-Cited by-同舟云学术

Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasia

Published:2003-04-21 Issue:1 Volume:34 Page:108-112
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Pollock Pamela M.,Cohen-Solal Karine,Sood Raman,Namkoong Jin,Martino Jeffrey J.,Koganti Aruna,Zhu Hua,Robbins Christiane,Makalowska Izabela,Shin Seung-Shick,Marin Yari,Roberts Kathleen G.,Yudt Laura M.,Chen Amy,Cheng Jun,Incao Arturo,Pinkett Heather W.,Graham Christopher L,Dunn Karen,Crespo-Carbone Steven M.,Mackason Kerine R.,Ryan Kevin B.,Sinsimer Daniel,Goydos James,Reuhl Kenneth R.,Eckhaus Michael,Meltzer Paul S.,Pavan William J.,Trent Jeffrey M.,Chen Suzie

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/ng1148.pdf

Reference20 articles.

1. Chen, S., Zhu, H., Wetzel, W.J. & Philbert, M.A. Spontaneous melanocytosis in transgenic mice. J. Invest. Dermatol. 106, 1145–1150 (1996).

2. Zhu, H. et al. Development of heritable melanoma in transgenic mice. J. Invest. Dermatol. 110, 247–252 (1998).

3. Colon-Teicher, L. et al. Genomic sequences capable of committing mouse and rat fibroblasts to adipogenesis. Nucleic Acids Res. 21, 2223–2228 (1993).

4. Budd, P.S. & Jackson, I.J. Structure of the mouse tyrosinase-related protein-2/dopachrome tautomerase (Tyrp2/Dct) gene and sequence of two novel slaty alleles. Genomics 29, 35–43 (1995).

5. Mackenzie, M.A., Jordan, S.A., Budd, P.S. & Jackson, I.J. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev. Biol. 192, 99–107 (1997).

Cited by 244 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabotropic Glutamate Receptors Type 3 and 5 Feature the “NeuroTransmitter-type” of Glioblastoma: A Bioinformatic Approach;Current Neuropharmacology;2024-09

2. AutoCancer as an automated multimodal framework for early cancer detection;iScience;2024-07

3. Immunotherapy in melanoma: advances, pitfalls, and future perspectives;Frontiers in Molecular Biosciences;2024-06-28

4. Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation;British Journal of Cancer;2024-06-20

5. Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma;Cell Death & Disease;2024-05-21